MassBio head: Vertex approval was ‘the most fulfilling day of my life’

//MassBio head: Vertex approval was ‘the most fulfilling day of my life’

MassBio head: Vertex approval was ‘the most fulfilling day of my life’

The FDA has approved a new treatment for upwards of 90 percent of patients with cystic fibrosis — the first such drug that could help MassBio CEO Bob Coughlin’s 17-year-old son.

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2019-10-22T18:41:21+00:00 October 22nd, 2019|Healthcare|

About the Author: